Coding

Part:BBa_K1333108:Experience

Designed by: Zhang Fangyingnan   Group: iGEM14_SYSU-China   (2014-10-17)


This experience page is provided so that any user may enter their experience using this part.
Please enter how you used this part and how it worked out.

Applications of BBa_K1333108

Use of K1333108 in iGEM Bielefeld 2016s genome wide mutator BBa_K2082116 and BBa_K2082117

BBa_K1333108 Review 1 chain
dnaQ926 is part of our genome wide mutator BBa_K2082117, but we also used it as a standalone mutator in BBa_K2082116.

Characterization

We characterized BBa_K1333108 as part of the genome wide mutators BBa_K2082116 and BBa_K2082117in E. coli Top10. We measured the performance in reversion assays and quantifiy the revertant frequency at two timepoints of a cultivation. The reversion frequencies f and the total cell count N enables us to calculate induced and basal mutation rate of BBa_K2082117 by using
As copy number we used 40 as determined in one of our high-throughput sequencing experiments.
Figure 1: Mutagensis rate of dnaQ926 (BBa_K2082116) and M6 (BBa_K2082117). The mutation rate of standalone dnaQ926 is (2.3±1.12)×10-6 bp-1×generation-1 induced and (6.67±4.09)×10-8 bp-1×generation-1 repressed. The mutation rate of M6 (assembly of six mutator genes amongst other dnaQ926) is (7.16±4.31)×10-6 bp-1×generation-1 induced and (2.51±3.18)×10-8 bp-1×generation-1 when repressed.
Furthermore, we determined precise dnaQ926 mutational spectrum via high-throughput sequencing.
Figure 2: Mutagenic spectrum of the genome wide mutators dnaQ926 (BBa_K2082116) and M6 (BBa_K2082117). Teh mutagenic spectrum was determined by distribution all oberserved mutations to the different mutations (reference base &arr; mutated base). The tables show the mutation distribution in percent. n is the number of counted mutation events.
Other important information for everyone using dnaQ926 are that expression of dnaQ926 decreases cell viability. Furthermore, even very low amounts of dnaQ926 create a strong mutator phenotype thus use of a very tightly controlled promoter is recommended. For this application iGEM Bielefeld 2016 used a modified PBAD, further repressed by addition of 20 mM glucose.

Application Protocol

  • Create competent cell of E. coli with arabinose expression genotype (e.g. araD139 Δ(ara-leu)7697).
  • For library generation
    • Transform mutator plasmid and plasmid with the gene of interest
    • Grow cells in LB mit appropiate anitbiotics
    • Induced mutagensis by addition of 20 mM arabinose upon reaching mid-log phase
    • Grow until saturation
  • Coupling with selection of improved proteins can be useful to screen more variants

Characterization protocols

  • Reversion assay
    • Transform reporter plasmid and pSB1C3::K2082117 into E. coli Top10
    • After regeneration inoculate prewarmed 10 mL LB with appropriate antibiotic and 20 mM glucose with 10 μL
    • Grow until OD600 ~0.3
    • Add 20 mM arabinose
    • Grow until saturation
    • Plate serial dilutions on LB agar plates with and without ampicillin
    • Determine total cell count and revertant count
    • Reversion frequency: number of Revertants/ number of viable cell count
  • NGS
    • Experimental setup as for reversion assays
    • Instead of plating isolate plasmids and use for Illumina MiSeq with the Illumina Nextera DNA Library Preparation Kit
    • Mapping of obtained read onto reference sequence, count coverage on non reference bases as number of mutations
    • Mutation rate: number of mutations/ number of sequenced bases
    • Divide mutations into groups based on refernce base and mutated base to obtain mutation spectrum
===User Reviews=== BBa_K1333108 StartReviews